2m 2m 2m 2m 2m 2m 2m
ARCUS BIOSCIENS (RCUS)
NYSE
$30.35+$0.01 (+0.03%)
Price as of Aug 21, 2026 7:30 PM EDT- $3.9BMarket Cap
- 188.13%1-Year Change
- BiotechnologyIndustry
ARCUS BIOSCIENS (RCUS)
$30.35+$0.01 (+0.03%)
RCUS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $30.34 | ||
Change | +$0.82 (+2.78%) | ||
Open | $29.89 | ||
High | $30.56 | ||
Low | $29.74 | ||
Previous Close | $29.52 | ||
Volume | 1,055,172 | ||
30-Day Average Volume | 1,218,267 | ||
1-Week Change | 2.92% | ||
1-Month Change | 2.92% | ||
1-Year Change | 188.13% | ||
3-Year Change | 59.94% | ||
5-Year Change | 6.91% | ||
Fundamentals | |||
Shares Outstanding | 127.3M | ||
Total Assets | $924.0M | ||
Market Cap | $3.9B | ||
Enterprise Value | $3.8B | ||
Period: QTR TTM FY | |||
Revenue | $8.0M | ||
Net Income | -$91.0M | ||
Free Cash Flow | -$119.0M | ||
EBIT | -$88.0M | ||
EBITDA | -$85.0M | ||
Net Working Capital | $558.0M | ||
EPS | -$0.72 | ||
Enterprise Value/EBITDA | -45 | ||
Enterprise Value/Revenue | 477 | ||
P/B | 8 | ||
P/E | -42 | ||
PEG | -1 | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -32 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue